ASPEN PHARMACR Balance Sheet - Quarterly (OTCMKTS:APNHY)

Add to My Stocks
$19.19 $0.26 (1.34%) APNHY stock closing price Jun 22, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our ASPEN PHARMACR stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our ASPEN PHARMACR stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing ASPEN PHARMACR revenue ASPEN PHARMACR operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The ASPEN PHARMACR balance sheet for 2018 Q2 shows cash on hand of $624.75M. The company has a debt to equity ratio of .

View and download ASPEN PHARMACR quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Fiscal year is Jul - Jun2018 Q22017 Q42017 Q22016 Q4
Marketable Securities----
Raw Materials-301.35M-249.84M
Work In Progress-345.45M-367.82M
Finished Goods-352.8M-381.7M
Notes Receivable----
Other Current Assets14.7M14.7M7.18M6.94M
Total Current Assets
Property Plant & Equipment-1.01B-909.14M
Accumulated Depreciation-294M-235.96M
Net Property Plant & Equipment
Investment & Advances----
Other Non-Current Assets----
Deferred Charges73.5M73.5M71.8M76.34M
Deposits & Other Assets147M117.6M129.24M83.28M
Total Assets
Notes Payable----
Accounts Payable698.25M757.05M718M576.02M
Current Portion Long-Term Debt1.62B1.39B674.92M756.46M
Current Portion Capital Leases----
Accrued Expenses----
Income Taxes Payable----
Other Current Liabilities654.15M411.6M366.18M131.86M
Total Current Liabilities
Deferred Taxes/Income169.05M154.35M136.42M124.92M
Convertible Debt----
Long-Term Debt2.17B2.12B2.56B2.27B
Non-Current Capital Leases----
Other Long-Term Liabilities441M543.9M459.52M430.28M
Total Liabilities
Minority Interest----
Preferred Stock----
Common Stock Net139.65M139.65M136.42M131.86M
Capital Surplus----
Retained Earnings-2.37B2.71B1.97B
Treasury Stock----
Other Liabilities3.12B654.15M-846.68M
Shareholders Equity3.26B3.17B2.84B2.95B
Total Liabilities & Shareholders Equity9B8.55B7.76B7.24B
All figures in USD. M: Millions of USD, B: Billions of USD.

Looking at ASPEN PHARMACR historical stock prices and the current ASPEN PHARMACR stock price can tell you how the stock price has moved, whereas the ASPEN PHARMACR PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like ASPEN PHARMACR owns and has monetary significance. APNHY assets grew from $8.55B in 2017 Q4 to $9B in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for ASPEN PHARMACR is $5.75B. Shareholders equity comes under liabilities as it is money the company owes the holders of APNHY stock.

ASPEN PHARMACR Balance Sheet - Key Ratios